SECTION 1: FACTUAL SUMMARY This pilot study used microcomputed tomography (microCT) and histological validation to examine the thoracic branches of the human vagus nerve, including cardiac, recurrent laryngeal, and pulmonary branches, building on prior evidence of organotopic organization in the pig cervical vagus nerve. Left and right vagus nerves (n=10) were dissected from human cadavers at the Evelyn Cambridge Surgical Training Centre, preserving cardiac, recurrent laryngeal, and pulmonary branches. Nerves were resected from below the last pulmonary branch to 2 cm cranial to average VNS cuff placement and 5 cm caudal from the nodose ganglion, yielding ~25 cm samples. Sutures marked branching points. Samples were fixed in 10% neutral buffered formalin, iodine-stained, microCT scanned, and subjected to histology and immunohistochemistry (IHC). Fascicles were segmented and traced in 5 nerves from branching points to cervical level using Vesselucida 360 software on microCT data, despite fascicular (not fiber) resolution. Analyzed features included fascicle trajectory, spatial arrangement at cervical level, longitudinal course and reorganization, fascicle and branch counts, distances between branches and merging/splitting events, and length of discrete fascicle travel before merging. Histology included Trichrome and H&E staining for nerve diameter, fascicle count/diameter, fiber count/diameter/type. IHC used neurofilament (NF) and myelin basic protein (MBP) antibodies to detect myelinated/non-myelinated fibers via intermediate filaments and myelin sheaths. Neurochemical/microtubule characteristics distinguished fiber types. ChAT immunostaining was not performed due to COVID-19 timeframe constraints and optimization issues on human tissue. Some cross-sections were missing due to practical limits. Ten nerves were microCT scanned and reconstructed; five proceeded to segmentation. Only three left and two right vagus nerves, fully traced from caudal to cranial, are presented.

Acute pancreatitis induces severe visceral pain that often resists standard treatment. This persists because the neural architecture relaying signals from the pancreas to the brain was previously incomplete. Researchers have identified a specific pancreas-brain axis mediated by the vagus nerve. This circuit works alongside spinal pathways to transmit inflammatory pain signals. The mechanism involves the cytokine TNF-α, which sensitizes TRPV1+ neurons in the nodose ganglia. These neurons relay to glutamatergic neurons in the nucleus tractus solitarius (NTS). The circuit then projects to glutamatergic neurons in the paraventricular nucleus of the hypothalamus (PVN). Inhibiting this NTS-to-PVN pathway effectively alleviates pain behaviors. This discovery provides a precise anatomical target for treating refractory inflammatory pain. https://pubmed.ncbi.nlm.nih.gov/38561100/ https://doi.org/10.1016/j.bbi.2024.03.047 https://pubmed.ncbi.nlm.nih.gov/41933645

Precision neuromodulation has reached a new threshold of noninvasive efficacy. Researchers have successfully utilized focused ultrasound (fUS) to target the cholinergic anti-inflammatory pathway (CAP) at the sub-organ level. This technique employs low-intensity pulsed ultrasound to stimulate neural projections from the vagus nerve directly into visceral organs, such as the spleen. In models of colitis, this stimulation resulted in a 60% reduction in tissue damage. Pro-inflammatory cytokines, specifically TNF-α and IL-6, were suppressed by 50-70%. The mechanism involves the activation of splenic nerve terminals, triggering acetylcholine release onto α7 nicotinic receptors. This biochemical cascade inhibits NF-κB signaling within immune cells. The result is a controlled dampening of the inflammatory response without surgical intervention or implanted hardware. Guided by real-time imaging, the method demonstrates precision comparable to invasive vagus nerve stimulation. This represents a significant advancement in bioelectronic medicine, utilizing acoustic energy to modulate systemic immunity. https://www.nature.com/articles/s41467-019-08750-9 https://www.pnas.org/doi/10.1073/pnas.1816771116 https://www.frontiersin.org/articles/10.3389/fnins.2021.670205/full https://pubmed.ncbi.nlm.nih.gov/30862827

The vagus nerve is the main parasympathetic nerve to the heart, providing rest and digest counterbalance to sympathetic fight or flight signals. Vagal stimulation slows heart rate, reduces contractile force, and promotes coronary artery dilation. The right vagus nerve has denser cardiac projections than the left, explaining avoidance of right-sided stimulation in VNS to prevent bradycardia or transient asystole. Through cardiac branches, the vagus nerve influences heart rate by slowing the sinoatrial node, rhythm by modulating atrioventricular node conduction, contractility by reducing force during rest, coronary blood flow by dilating arteries, baroreceptor sensitivity for blood pressure responses to position changes, and heart rate variability. Heart rate variability (HRV) measures variation in time between consecutive heartbeats. Higher HRV reflects dynamic sympathetic-parasympathetic interplay, stronger vagal tone, better autonomic balance, improved cardiovascular health, lower stress, and reduced mortality risk. Low HRV indicates vagal withdrawal and sympathetic dominance, linked to increased risk of coronary artery disease, heart attacks, sudden cardiac death, heart failure progression, hypertension, type 2 diabetes, all-cause mortality, chronic stress, burnout, anxiety, depression, poor physical fitness, inflammation, aging, and reduced longevity. Vagus nerve stimulation (VNS) targets cardiovascular conditions. In chronic heart failure, VNS restores autonomic balance, potentially improving cardiac function, exercise tolerance, and quality of life; early trials show promise as adjunctive therapy. For arrhythmia management, VNS modulates electrical conduction, relevant for atrial fibrillation and supraventricular arrhythmias, potentially reducing episodes or enhancing treatment outcomes. In hypertension, VNS enhances baroreflex sensitivity for blood pressure regulation during postural changes and stress, offering benefits for resistant cases. Post-myocardial infarction, VNS addresses persistent autonomic dysfunction to improve long-term outcomes and prevent recurrence. In coronary artery disease, vagal stimulation promotes vasodilation, improves endothelial function, and may reduce atherosclerotic progression.

Stop pretending your "mindset" is in control. The brain isn't the CEO of your life; it’s just the PR department for a single nerve. Guidebook on it here: https://www.skool.com/vagus/classroom/f927d70f The vagus nerve is the literal tether between your consciousness and your anatomy. It dictates your mood, your immunity, and your reality before you even process a thought. We’ve been taught that stress is a mental hurdle. It isn't. Low vagal tone isn't a "bad day"—it’s a hardware failure. If your heart rate variability (HRV) is tanking, your "positive thinking" is biologically useless. This nerve is the puppet master, stretching from the brainstem to the gut to orchestrate your entire existence. Read more: https://www.skool.com/vagus/classroom/f927d70f You aren't "anxious." Your hardware is simply out of tune. We obsess over psychology while ignoring the biological wiring that makes psychology possible. Is your "willpower" real, or are you just a slave to your autonomic tone? True resilience isn't found in a self-help book. It's built in the nerves.